Testosterone Treatment of Men With Mild Cognitive Impairment and Low Testosterone Levels

66Citations
Citations of this article
107Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: This study investigated the effects of testosterone (T) treatment on cognition, mood, and quality of life in men with mild cognitive impairment (MCI) and low serum T levels. Methods: A total of 351 community-dwelling men were screened, and 37 men evidenced both MCI and low T of whom 27 agreed for further screening. Twenty-two met all the study inclusion/ exclusion criteria and enrolled in a 6-month randomized, double-blind, placebo-controlled study. Results: Total T levels significantly increased in the T treatment group. No significant changes were observed in measures of cognition, mood, or quality of life other than improvement in 1 objective measure of verbal memory (P < .05) and decreased depression symptoms (P < .02) in the treatment group. Conclusions: Testosterone treatment may modestly improve verbal memory and depression symptoms in men with both MCI and low T.

Cite

CITATION STYLE

APA

Cherrier, M. M., Anderson, K., Shofer, J., Millard, S., & Matsumoto, A. M. (2015). Testosterone Treatment of Men With Mild Cognitive Impairment and Low Testosterone Levels. American Journal of Alzheimer’s Disease and Other Dementias, 30(4), 421–430. https://doi.org/10.1177/1533317514556874

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free